Skip to main content
. 2021 Mar 16;27(5-6):336–350. doi: 10.1089/ten.tea.2020.0092

FIG. 3.

FIG. 3.

Comparative analysis of indications for cell and tissue-engineered therapies in Europe for the combined years of 2016 and 2017, sorted by mode of processing (A) expansion, (B) transduction, (C) sorting, (D) process handling, and (E) facility of processing. Data used for this chart were derived from this study, and five previous reports (1–5).